Evidence map›Paper›PMID 39240985›Full record

ArticleeLife2024

ImmCellTyper facilitates systematic mass cytometry data analysis for deep immune profiling.

Jing Sun, Desmond Choy, Nicolas Sompairac, Shirin Jamshidi, Michele Mishto, Shahram Kordasti

Abstract read
In one paragraph

Article in eLife, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jing Sun *Centre for Inflammation Biology and Cancer Immunology & Peter Gorer Department of Immunobiology, King's College London, London, United Kingdom.ORCID https://orcid.org/0009-0001-7102-7556
Desmond Choy *School of Cancer and Pharmaceutical Sciences, King's College London, London, United Kingdom.
Nicolas SompairacSchool of Cancer and Pharmaceutical Sciences, King's College London, London, United Kingdom.ORCID https://orcid.org/0000-0001-8759-2077
Shirin JamshidiSchool of Cancer and Pharmaceutical Sciences, King's College London, London, United Kingdom.ORCID https://orcid.org/0000-0001-8290-6698
Michele MishtoCentre for Inflammation Biology and Cancer Immunology & Peter Gorer Department of Immunobiology, King's College London, London, United Kingdom.
Shahram KordastiSchool of Cancer and Pharmaceutical Sciences, King's College London, London, United Kingdom.ORCID https://orcid.org/0000-0002-0347-4207

Funding

Blood Cancer UK Ref. 22009Cancer Research UK CTRQQR-2021/100004
6 · The paper itself

Abstract

Mass cytometry is a cutting-edge high-dimensional technology for profiling marker expression at the single-cell level, advancing clinical research in immune monitoring. Nevertheless, the vast data generated by cytometry by time-of-flight (CyTOF) poses a significant analytical challenge. To address this, we describe ImmCellTyper (https://github.com/JingAnyaSun/ImmCellTyper), a novel toolkit for CyTOF data analysis. This framework incorporates BinaryClust, an in-house developed semi-supervised clustering tool that automatically identifies main cell types. BinaryClust outperforms existing clustering tools in accuracy and speed, as shown in benchmarks with two datasets of approximately 4 million cells, matching the precision of manual gating by human experts. Furthermore, ImmCellTyper offers various visualisation and analytical tools, spanning from quality control to differential analysis, tailored to users' specific needs for a comprehensive CyTOF data analysis solution. The workflow includes five key steps: (1) batch effect evaluation and correction, (2) data quality control and pre-processing, (3) main cell lineage characterisation and quantification, (4) in-depth investigation of specific cell types; and (5) differential analysis of cell abundance and functional marker expression across study groups. Overall, ImmCellTyper combines expert biological knowledge in a semi-supervised approach to accurately deconvolute well-defined main cell lineages, while maintaining the potential of unsupervised methods to discover novel cell subsets, thus facilitating high-dimensional immune profiling.

Indexed as

Data AnalysisFlow CytometrySingle-Cell AnalysisCluster AnalysisHumansSoftwarecomputational biologycomputational frameworkCyTOFhumanimmune profilingimmunologyinflammationsystems biology

Identifiers

PMID39240985
PMCPMC11379455

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.